Back
Phathom Pharmaceuticals Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
6
PHAT
Phathom Pharmaceuticals
Last Price:
$6.94
Seasonality Move:
-11.29%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.64 | Sell |
| 20-day SMA: | 7.87 | Sell |
| 50-day SMA: | 10.41 | Sell |
| 200-day SMA: | 12.05 | Sell |
| 8-day EMA: | 7.5 | Sell |
| 20-day EMA: | 8.03 | Sell |
| 50-day EMA: | 9.89 | Sell |
| 200-day EMA: | 11.69 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 33.09 | Sell |
| Chaikin Money Flow: | -249879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.49 - 8.67) | Sell |
| Bollinger Bands (100): | (9.18 - 17.68) | Sell |
Phathom Pharmaceuticals Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 6.95 while PHAT 8-day simple moving average is 7.64, which is a Sell signal.
-
The stock price of PHAT is 6.95 while Phathom Pharmaceuticals 20-day SMA is 7.87, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 10.41 while PHAT share price is 6.95, making it a Sell technically.
-
PHAT stock price is 6.95 and Phathom Pharmaceuticals 200-day simple moving average is 12.05, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
6
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $6.95. The Score for PHAT is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
475.2M
Price in USD:
6.95
Share Volume:
841.6K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
6.07
Sell
6
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 6.95 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 6.95 while PHAT 8-day exponential moving average is 7.50, which is a Sell signal.
-
The stock price of PHAT is 6.95 while Phathom Pharmaceuticals 20-day EMA is 8.03, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 9.89 while PHAT share price is 6.95, making it a Sell technically.
-
PHAT stock price is 6.95 and Phathom Pharmaceuticals 200-day simple moving average is 11.69, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $1.90 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 33.09, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (7.49 - 8.67), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.18 - 17.68), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.